NCT00755326View on ClinicalTrials.gov

Dose Escalation Study Of Chinese Herbs In Osteoarthritis Of The Knee

PHASE2CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

April 30, 2010

Study Completion Date

July 31, 2010

Conditions
Osteoarthritis of the Knee
Interventions
DRUG

HLXL

Two daily dosages will be investigated. Huo-Luo-Xiao-Ling (HLXL) dose (10 capsules/day or 4,000mg/day) in the first 2 weeks to evaluate safety. If no adverse effects were observed, the dose was increased to 14 capsules per day (5,600 mg/ day) for the subsequent 6 weeks.

Trial Locations (1)

21207

University of Maryland Center for Integrative Medicine Kernan Hospital, Baltimore

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

University of Maryland, Baltimore

OTHER

NCT00755326 - Dose Escalation Study Of Chinese Herbs In Osteoarthritis Of The Knee | Biotech Hunter | Biotech Hunter